Free Trial
NASDAQ:NBTX

Nanobiotix (NBTX) Stock Price, News & Analysis

Nanobiotix logo
$5.26 +0.04 (+0.77%)
As of 07/18/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nanobiotix Stock (NASDAQ:NBTX)

Key Stats

Today's Range
$5.21
$5.30
50-Day Range
$3.33
$5.76
52-Week Range
$2.76
$6.00
Volume
4,408 shs
Average Volume
15,529 shs
Market Capitalization
$247.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Moderate Buy

Company Overview

Nanobiotix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

NBTX MarketRank™: 

Nanobiotix scored higher than 38% of companies evaluated by MarketBeat, and ranked 691st out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nanobiotix has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Nanobiotix has received no research coverage in the past 90 days.

  • Read more about Nanobiotix's stock forecast and price target.
  • Percentage of Shares Shorted

    0.01% of the float of Nanobiotix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently decreased by 50.44%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nanobiotix does not currently pay a dividend.

  • Dividend Growth

    Nanobiotix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.01% of the float of Nanobiotix has been sold short.
  • Short Interest Ratio / Days to Cover

    Nanobiotix has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nanobiotix has recently decreased by 50.44%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    Only 1 people have added Nanobiotix to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nanobiotix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.45% of the stock of Nanobiotix is held by insiders.

  • Percentage Held by Institutions

    Only 38.81% of the stock of Nanobiotix is held by institutions.

  • Read more about Nanobiotix's insider trading history.
Receive NBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter.

NBTX Stock News Headlines

Missed the Run So Far? This Is Your Second Chance
According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.
See More Headlines

NBTX Stock Analysis - Frequently Asked Questions

Nanobiotix's stock was trading at $2.87 at the beginning of 2025. Since then, NBTX shares have increased by 83.3% and is now trading at $5.26.

Nanobiotix (NBTX) raised $95 million in an initial public offering on Friday, December 11th 2020. The company issued 6,500,000 shares at a price of $14.69 per share. Jefferies, Evercore ISI, UBS Investment Bank and Gilbert DuPont acted as the underwriters for the IPO.

Shares of NBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanobiotix investors own include PayPal (PYPL), Sirius XM (SIRI), Ardelyx (ARDX), BridgeBio Pharma (BBIO), Cogent Communications (CCOI), Citius Pharmaceuticals (CTXR) and Datadog (DDOG).

Company Calendar

Today
7/20/2025
Next Earnings (Estimated)
9/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NBTX
CIK
1760854
Fax
N/A
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+52.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.04
Quick Ratio
1.04

Sales & Book Value

Annual Sales
-$11.61 million
Price / Sales
-21.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.51) per share
Price / Book
-3.48

Miscellaneous

Outstanding Shares
47,133,000
Free Float
45,507,000
Market Cap
$247.92 million
Optionable
Not Optionable
Beta
0.41

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:NBTX) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners